Investment Case

– 4basebio: a manufacturer of pharmaceutical grade DNA
– New manufacturing processes
– Pursueing vertical integration for gene therapy and DNA vaccines

An increasing demand for pharmaceutical grade DNA
4basebio designs a new synthetic production:
– Highly effective
– Scalable
– Fast
– Safer

– Fully synthetic, scalable and cell-free manufacturing process
– High yield
– Proprietary enzyme technologies
– Wide range of applications

First Berlin, Analyst Christian Orquera, 15 July 2020: “AIMING TO DISRUPT THE DNA MANUFACTUING MARKET”

What does 4basebio do? 4basebio is developing a production method for next generation synthetic DNA (hairpin-DNA, hp-DNA). Our products will be the active ingredient in future gene therapies and gene…